13 #ScientificSessions26 ScientificSessions.org Hypertension, Sodium and Sleep: An Integrated Approach to Cardiovascular Health Emerging research shows that blood pressure, sodium intake and sleep quality are closely interconnected. Addressing these factors together can improve patient outcomes and support comprehensive cardiovascular care. Explore educational topics, including: • How sodium intake—from both diet and prescription medications—affects blood pressure and cardiovascular risk • Practical approaches to reduce sodium exposure and enhance patient outcomes • Strategies for integrating sleep disorders screening and sleep health improvement • Cross-disciplinary insights and tools to support personalized care Expert-led podcasts, a clinical toolkit, and more, developed in collaboration with Brigham and Women's Hospital, will help you apply these strategies in practice. Scan now to find education and additional resources. © Copyright 2026 American Heart Association, Inc., a 501(c)(3) not-for-profit. All rights reserved. Unauthorized use prohibited. WF-1852240 9/26 Jazz Pharmaceuticals, Inc. is proud to support the American Heart Association’s Hypertension, Sodium and Sleep Professional Education Initiative. Paid Advertisement Cardiac computed tomography has long been an important tool for assessing coronary luminal stenosis, but recent advances are expanding its use to a more comprehensive evaluation of coronary inflammation, myocardial tissue characteristics and disease processes particularly relevant to women. A Sunday joint session with the American Heart Association and the Society of Cardiovascular Computed Tomography, “New Horizons in Cardiac Computed Tomography: American Heart Association Joint Session With Society of Cardiovascular Computed Tomography,” will explore this evolution by highlighting how advances in cardiac CT can improve risk assessment, refine diagnosis and potentially support more personalized patient management. Diana Litmanovich, MD, FNASCI, council chair of the Cardiovascular Radiology and Intervention Council, is moderating the session. She is an associate professor of radiology at Harvard Medical School in Boston. Litmanovich said the session will highlight three complementary areas involving emerging imaging biomarkers and techniques that may improve disease characterization and enhance risk stratification: • Pericoronary adipose tissue attenuation • CT-based myocardial tissue characterization • Imaging of spontaneous coronary artery dissection (SCAD) Litmanovich, who is also vice chair of practitioner and population health at Beth Israel Deaconess Medical Center in Boston, said pericoronary adipose tissue attenuation is an emerging biomarker that provides insight into coronary inflammation and may offer information about coronary atherosclerotic activity beyond conventional anatomic assessment. “It represents a shift toward characterizing the biological activity of coronary artery disease, rather than simply measuring the degree of luminal narrowing,” she said. Litmanovich said this part of the discussion will highlight the gap between research applications and clinical use, focusing on two main questions: • Can coronary artery CT tell us something about the activity and vulnerability of atherosclerotic disease beyond what we see in the lumen and plaque? • Can inflammation be detected when the coronary lumen appears to be normal? In the area of CT-based myocardial tissue characterization, Litmanovich said advances in CT acquisition, reconstruction and quantitative analysis are expanding the potential to characterize myocardial tissue beyond conventional morphology and function. “These developments may improve the evaluation of myocardial disease, complement cardiac MRI and broaden the clinical applications of cardiac CT,” she said. Litmanovich, whose research focuses in part on cardiovascular disease in women, said greater understanding of its distinct presentations and mechanisms is driving interest in tailored imaging strategies, including those used for SCAD. “The session will address the role of cardiac imaging in evaluating Cardiac CT offers a clearer picture of CVD Diana Litmanovich, MD, FNASCI Advances in imaging move beyond coronary narrowing to reveal disease activity, characterize myocardial tissue and refine diagnosis. UPCOMING SESSION New Horizons in Cardiac Computed Tomography: American Heart Association Joint Session With Society of Cardiovascular Computed Tomography 3:30–4:45 p.m. | Sunday, Nov. 8 S104B See CARDIAC CT, page 17
RkJQdWJsaXNoZXIy MjI2NjI=